| |
Lexapro
The Road Back Program. Step by step procedure
of how to taper off or quit taking Lexapro and eliminate Lexapro withdrawal side
effects. Click here
All other links open a new browser window.
Lexapro: Full Lexapro Description -
Click here - Source:
FDA
Lexapro: Increased Risk of Neonatal Persistent Pulmonary
Hypertension
Click
here - Source:
FDA ALERT [7/2006]
Lexapro: Patient Information
Click here - Source:
FDA
Lexapro: Lexapro News
Click here
Partial Lexapro description:
Pharmacokinetics
The single- and multiple-dose
pharmacokinetics of Lexapro are linear and dose-proportional in a dose range of
10 to 30 mg/day. Biotransformation of Lexapro is mainly hepatic, with a mean
terminal half-life of about 27-32 hours. With once-daily dosing, steady state
plasma concentrations are achieved within approximately one
week. At steady state, the
extent of accumulation of Lexapro
in plasma in young healthy subjects was 2.2-2.5
times the plasma concentrations observed after a single dose. The tablet and the
oral solution dosage forms of Lexapro oxalate are bioequivalent.
Absorption and Distribution
Following a single oral dose (20 mg tablet or solution)
of Lexapro, peak blood levels occur at about 5 hours. Absorption of Lexapro
is not affected by food.
The absolute bioavailability of citalopram is about 80%
relative to an intravenous dose, and the volume of distribution of
citalopram is about 12 L/kg. Data specific on escitalopram are unavailable.
The binding of Lexapro to human plasma proteins is
approximately 56%.
Metabolism and Elimination
Following oral
administrations of Lexapro, the fraction of drug recovered in the urine as
Lexapro and S - demethylcitalopram (S-DCT) is about 8% and 10%,
respectively. The oral clearance of
Lexapro
is 600 mL/min, with approximately 7% of that due to renal clearance.
Lexapro
is metabolized to S-DCT and S-didemethylcitalopram (S-DDCT). In humans,
unchanged Lexapro
is the predominant compound in plasma. At steady state, the concentration of the
Lexapro
metabolite S-DCT in plasma is approximately one-third that of
Lexapro.
The level of S-DDCT was not detectable in most subjects.
In vitro
studies show that
Lexapro
is at least 7 and 27 times more potent than S - DCT and S-DDCT, respectively, in
the inhibition of serotonin reuptake, suggesting that the metabolites of
Lexapro
do not contribute significantly to the antidepressant actions of
Lexapro.
S-DCT and S-DDCT also have no or very low affinity for serotonergic
(5-HT1-7) or other receptors including alpha- and beta-adrenergic,
dopamine (D1-5), histamine (H1-3),
muscarinic (M1-5), and benzodiazepine receptors. S-DCT and
S-DDCT also do not bind to various ion channels including Na+, K+, Cl-,
and Ca++ channels.
A full description can be found
Click here -
Source:
FDA
To visit the Lexapro manufactures site
Click here
Other Lexapro info from the FDA
Click here
Study Of Drug Therapy For Compulsive Buying Yields A Puzzle
Researchers at the Stanford University School of Medicine say they are puzzled
by findings from their new study indicating that an antidepressant, which
previously showed promise in treating a behavioral disorder known as compulsive
buying, did not result in a sustained benefit for the patients who took it.
The medication is Lexapro, a commonly prescribed
antidepressant sold under the brand name Lexapro. In the study, researchers
found no difference in the relapse rate of people with compulsive-buying
disorder when they continued to take Lexapro compared with those who had been
switched to a placebo. Those results are perplexing to lead author Lorrin Koran,
MD, professor of psychiatry and behavioral sciences emeritus, because he had
done a similar study in 2003 that found compulsive-buying patients improved
stably after taking another antidepressant medication, citalopram, in which
Lexapro is the active ingredient.
"It was a shock that, when we did the trial again with the
active ingredient, it didn't work exactly the same way. It should have," said
Koran, who also led the 2003 study. The results of the latest double-blind,
placebo-controlled trial will be published in the April issue of the Journal of
Clinical Psychopharmacology.
Koran said the unexpected result from the new study may in
part be due to the small number of participants in the double-blind phase of the
trial, which involved just 17 subjects whose buying behavior had markedly
improved in the initial stage of the trial when they were all taking Lexapro. Of
the nine randomly assigned to take a placebo in the later part of the trial, six
relapsed, while five of eight continuing on Lexapro relapsed.
But the study size is likely not the only factor influencing
the outcome of the trial.
"I don't think we're dealing with one pure biological
disorder," said Koran. "We're dealing with a behavior that has different
biological roots in different people and therefore we may have had very
different groups of people in the two studies."
In the 2003 study, 24 patients were all initially given
citalopram for the open-label portion of the study, during which they all knew
they were taking citalopram. Fifteen of those patients reported marked
improvements in their buying behaviors. For the second portion of that trial,
these 15 patients were randomly assigned to take either citalopram or a placebo
without knowing which one they were taking. Of seven patients who continued
taking the medication, all seven maintained their improvement, while five of the
eight patients receiving a placebo relapsed.
People suffering from compulsive buying disorder are
preoccupied with shopping for unneeded items and are frequently unable to resist
purchasing them. The problem is not a simple lack of willpower, said Koran, who
described it as being as real a disorder as other impulsive behaviors such as
alcoholism and pathological gambling. Sufferers of the disorder commonly wind up
with closets or rooms filled with unwanted purchases, amassing thousands of
dollars of debt in the process and often damaging their relationships by lying
to loved ones about their purchases.
A recent nationwide, random-sample telephone survey conducted
by Koran and his colleagues indicated that compulsive buying appeared to affect
nearly 6 percent of the U.S. population, with nearly equal proportions of men
and women affected.
Koran said a larger double-blind, placebo-controlled clinical
trial is needed to reach a conclusive result regarding the effectiveness of
Lexapro in treating patients with compulsive buying disorder.
He suggested future clinical trials might be able to yield
more information if they were combined with imaging studies of the patients'
brains. He cited recent work by Brian Knutson, PhD, assistant professor of
psychology and neuroscience, whose recent imaging studies suggest that
scientists might be able to directly visualize brain activity related to
compulsive purchases.
"We would look for a difference in the brain activation
patterns of those who respond to the drug vs. those who don't," said Koran.
The inconclusive nature of the results from the latest trial
of Lexapro should not discourage anyone suffering from compulsive buying from
seeking treatment, since several types of treatment seem to be helpful, Koran
emphasized.
Other co-authors include Hugh Brent Solvason, MD, PhD,
assistant professor of psychiatry and behavioral sciences; Nona Gamel, clinical
research manager; and Emily Smith, clinical research coordinator.
Note: This story
has been adapted from a news release issued by Stanford University Medical
Center.
Lexapro side effects and Lexapro withdrawal side
effects
- Lexapro withdrawal - Anorexia – No longer having a
desire to eat.
- Lexapro withdrawal - Apothous Stomatitis – Painful
red and swollen open sores on a mucus membrane of the mouth commonly called
a canker sore.
- Lexapro withdrawal - Ataxia – Loss of the ability
to move the body with coordination.
- Lexapro withdrawal - Arterial Fibrillation – A
condition of abnormal twitching of the muscles in the blood vessels that
moves the oxygenated blood from the heart to the rest of the body. The
unusual twitching is rapid and irregular and replaces the normal rhythm of
contraction of the muscle, which sometimes causes a lack of circulation and
pulse.
- Lexapro withdrawal - Blood Cholesterol Increased –
An abnormal condition where there is a greater amount in the blood of the
oily/fatty substances known as cholesterol. Cholesterol is a necessary
part of living cells (along with proteins and carbohydrates). Because
cholesterol only slightly dissolves in water, it can build up on the walls
of the blood vessels, therefore blocking/decreasing the amount of blood
flow, which causes blood pressure to go up. If not corrected, this
condition is associated with coronary artery disease.
- Lexapro withdrawal - Blood Creatinine Increased –
A greater than normal number of creatinine or muscular chemical waste
molecules in the blood. Creatinine plays a major role in energy production
in muscles. Since creatinine levels are normally maintained by the kidneys,
Blood Creatinine Increased is an indicator of kidney malfunction or failure.
- Lexapro withdrawal - Blood in Stool – The blood
that is in your bowel movement usually comes from any place along your
digestive tract (from your mouth to your anus). The stool can appear black
and foul-smelling (usually from the upper part of your digestive tract) or
red or maroon-colored (usually from the large intestine area). Hemorrhoids
are the usual cause for blood in the bowels.
8. Lexapro withdrawal - Bundle Branch Block Right –
These are specialized cells in the upper right heart chamber and are the heart’s
pacemaker. They send electrical signals to the heart that keeps it beating
or contracting regularly. Normally the signal goes to the lower heart
chambers at the same time through the bundle of His (hiss) on both the left and
right sides of the heart, so the lower chambers contract at the same time.
When the bundle is damaged on the right side, the signal does not fire at the
same time as the left, which changes the pace of blood flow. This can lead
to a person fainting.
- Lexapro withdrawal - Cardiac Failure – A heart
disorder where the heart does not function as usual and may completely stop
working.
- Lexapro withdrawal - Cardiac Failure Congestive –
The body is asking for the heart to supply more blood than it is capable of
producing and maintaining. Normally, a body can tolerate an increased
amount of work for quite some time. The condition is characterized by
weakness, shortness of breath, and a fluid build-up in the body tissues
causing swelling.
- Lexapro withdrawal - Cold Sweat – The skin is
clammy and moist and you feel chilled. This is a reaction to a shock or
pain as well as to fear and nervousness.
- Lexapro withdrawal - Colitis – A condition where
the large intestine becomes irritated from the use of the drug.
- Lexapro withdrawal - Coronary Artery Disease – A
condition where the blood vessels that mainly carry the blood away from the
heart become clogged up or narrowed usually by fatty deposits. The first
symptom is pain spreading from the upper left body caused by not enough
oxygen reaching the heart.
- Lexapro withdrawal - Dehydration – An extreme loss
of water from the body or the organs of the body as in sickness or not
drinking enough fluids.
- Lexapro withdrawal - Diplopia – The condition
where a person is looking at one object and instead of normally seeing just
the one object he sees two. This is also called double vision.
- Lexapro withdrawal - Diverticulitis – There are
pouches or sacs on the inside of the intestines that look like fingers.
This increases the area for the body to absorb nutrients as they pass
through the intestines. These sacs become irritated and swollen and end up
trapping waste that would normally be eliminated, causing pain and
constipation.
- Lexapro withdrawal - Dysarthria – The inability to
control the mouth muscles when forming words so the words are not clearly
spoken and heard.
- Lexapro withdrawal - Dyslipidemia – The normal fat
metabolism in the blood is interfered with.
- Lexapro withdrawal - Dysphagia – Trouble
swallowing or the inability to swallow.
- Lexapro withdrawal - Ecchymosis – When a blood
vessel breaks and creates a purple discoloration of the skin.
- Lexapro withdrawal - Edema – An abnormal build up
of excess fluids in the cells, tissues, and the spaces between the tissues
creating swelling.
- Lexapro withdrawal - Edema Peripheral – The
abnormal build up of fluids in the tissues of the ankles and legs causing
painless swelling in the legs, ankles, and feet. If you squeeze the swollen
area it leaves an indentation on the skin for a few minutes.
- Lexapro withdrawal - Ejaculation Delayed – The man
is not able to release sperm either during sexual intercourse or with manual
stimulation in the presence of his sexual partner in spite of his wish to do
so.
- Lexapro withdrawal - Ejaculation Dysfunction – A
condition where the man has one or more of the following symptoms: He is
not able to have an erection, not able to have an orgasm, has a decreased
interest in sex, is sexually inhibited, or it is painful to ejaculate sperm.
- Lexapro withdrawal - Erectile Dysfunction –
Incapable of having sexual intercourse. Even though a man desires sex he is
inhibited in his sexual activity and is unable to have or maintain an
erection of the penis.
- Lexapro withdrawal - Erythema – a skin redness
caused by the swelling with blood of the tiny blood vessels of the skin as
in burns.
- Lexapro withdrawal - Erythematous Rash – Redness
of the skin from the swelling of the tiny blood vessels with skin irritation
(itching, burning, tingling, pain) and breakouts (eruptions).
- Lexapro withdrawal - Esophageal Stenosis Acquired
– The tube that moves food from the mouth to the stomach narrows.
- Lexapro withdrawal - Exfoliative Dermatitis – The
unusual and not normal condition of scaling and shedding of the skin cells.
The skin is usually red colored.
- Lexapro withdrawal - Face Edema – The tissues of
the face become swollen.
- Lexapro withdrawal - Feeling Jittery – A physical
sensation of nervous unease.
- Lexapro withdrawal - Gastric Irritation – An
inflamed and sore stomach.
- Lexapro withdrawal - Gastric Ulcer – An open,
irritated, and infected sore in the wall of the stomach.
- Lexapro withdrawal - Gingivitis – Sore, swollen
and red gums in the mouth that bleed easily.
- Lexapro withdrawal - Glaucoma – The delicate nerve
to the eye, the optic nerve, becomes easily damaged with the build-up of
excess fluid pressure within the eyeball. The first sign of glaucoma is
loss of peripheral (side) vision. It can progress to total blindness.
- Lexapro withdrawal - Hepatic Steatosis – Excessive
amounts of fat in the liver.
- Lexapro withdrawal - Hyperhidrosis – The
triggering of an excess of sweat being produced on the soles of the feet,
the palms, or the underarms which can cause embarrassment or losing grip on
a pen or other items.
- Lexapro withdrawal - Hyperkeratosis – An abnormal
enlargement of the skin tissues causing the skin cells to increase in size.
- Lexapro withdrawal - Hyperlipidemia – An
abnormally high number of fat cells in the blood.
- Lexapro withdrawal - Hypertriglyceridemia – Too
many triglycerides in the blood.
Triglycerides are three fatty acids bound together in one
molecule stored by the body and available to create high levels of energy when
used.
- Lexapro withdrawal - Hypoesthesia – A partial loss
of sensation or general loss of awareness.
- Lexapro withdrawal - Impaired Gastric Emptying –
The contents of the stomach are not passed into the intestines as normal due
to the stomach losing the muscular strength to do so.
- Lexapro withdrawal - Increased White Blood cell Count
– This is an increase in the number of cells in the blood that are
responsible for the removal of bacteria and other unwanted particles. They
fight disease and infection by enclosing foreign particles and removing
them. An example of a disease that would increase white blood cell count
would be Leukemia.
- Lexapro withdrawal - Insomnia – Not able to fall
asleep or sleeping for a shorter time than desired, thus not being able to
properly rest and feeling un-refreshed. As a result, a person can become
irritable, have difficulty concentrating and feel a lack of energy. This
can be caused by stimulants such as by caffeine or drugs or by mental
anxiety and stress. Mental stress can be communicated and relieved.
- Lexapro withdrawal - Irritable Bowel Syndrome – A
painful condition where either the muscles or the nerves of the lower
intestines, are not responding normally. This results in an alternating
condition of diarrhea followed by constipation, back and forth.
- Lexapro withdrawal - Keratoconjunctivitis Sicca –
A condition where the outer coating of the eyeball is dry because of a
decrease in the normal amount of tears in the eye. As a result, the eyeball
and inside of the eyelid thickens and hardens sometimes causing the vision
to be less sharp.
- Lexapro withdrawal - Leukopenia – An unnaturally
low number of white blood cells circulating in the blood.
- Lexapro withdrawal - Loose Stools – The bowel
movement is runny instead of formed.
- Lexapro withdrawal - Lower Abdominal Pain – A
hurtful irritation of the nerve endings in the area of the hipbones housing
the lower digestive tract. Pain usually means tissue damage.
- Lexapro withdrawal - Lymphadenopathy – The lymph
nodes, where the immune cells are located, become larger than is normal
because of a high concentration of white blood cells.
- Lexapro withdrawal - Macular Degeneration – The
gradual loss of central vision, which is the sharpest vision while
peripheral eyesight, is unaffected.
- Lexapro withdrawal - Maculopathy – An abnormal
condition of the yellow spot of the eye, which is located in the center of
the inner lining of the eyeball and connected to the main nerve to the eye
and is responsible for sharp vision.
- Lexapro withdrawal - Mania – Unusually irrational,
excessive and/or exaggerated behavior or moods ranging from enthusiasm,
sexuality, gaiety, impulsiveness and irritability to violence.
- Lexapro withdrawal - Melena – Abnormally darkly
colored stools as a result of hemorrhaging in the digestive tract where the
blood has interacted with the digestive juices creating the dark color in
the bowel movement.
- Lexapro withdrawal - Micturition Urgency – A
sudden desire to urinate usually followed by leakage.
- Lexapro withdrawal - Mood Swings – An emotional
shifting as from a state of happiness to a state of depression for a period
of time.
- Lexapro withdrawal - Myocardial Infarction – The
blood going to the heart is delayed or stopped causing middle muscle tissue
in the heart wall to die.
- Lexapro withdrawal - Nasopharyngitis – Irritation,
redness and swelling tissues in the nose and the tube leading from the mouth
to the voice box as well as the tubes leading to the ears.
- Lexapro withdrawal - Nephropathy – An abnormally
functioning or diseased kidney.
- Lexapro withdrawal - Nervousness – Jumpy, jittery,
anxious, and troubled with an irritable temperament.
- Lexapro withdrawal - Night Sweats – The
water-salt, waste product the skin releases is called sweat or
perspiration. With night sweats you become wide awake in the middle of the
night shivering and cold and wet with your sheets/pajamas soaked in
perspiration making it difficult to go back to sleep.
- Lexapro withdrawal - Nightmare – Dreams that make
you afraid or leave feelings of fear, terror, and upset long after waking
up.
- Lexapro withdrawal - Orgasm Abnormal – Unable to
have an orgasm with normal sexual stimulation.
- Lexapro withdrawal - Oropharyngeal Swelling – A
swelling in the area from the soft part of the roof of the mouth to the back
of the mouth.
- Lexapro withdrawal - Pain in Extremity – A painful
feeling in the legs, arms, hands, and feet.
- Lexapro withdrawal - Pharyngolaryngeal Pain – Pain
in the area of the respiratory tract (organs of breathing) from the throat
to the voice box and above the windpipe.
- Lexapro withdrawal - Photopsia – A condition where
a person see lights, sparks or colors in front of your eyes.
- Lexapro withdrawal - Photosensitivity Reaction –
An exaggerated sunburn reaction that is not normal in proportion to the
amount of exposure to the light.
- Lexapro withdrawal - Pollakiuria – Urinating much
more frequently than normal – as often as once every five to fifteen
minutes.
- Lexapro withdrawal - Pressure of Speech – A
condition where the individual cannot voice his ideas fast enough with the
pressure of there being not enough time to say it.
- Lexapro withdrawal - Pruritic Rash – Extremely
itchy, red, swollen bumps on the skin.
- Lexapro withdrawal - Pyrexia – Fever or the
increase in body temperature that is usually a sign of infection.
- Lexapro withdrawal - Retinal Detachment – The thin
layer lining the back of the eyeball (the retina) detaches from the back of
the eyeball. This thin layer is like the film of a camera because it sends
the images a person views to the brain. When it detaches it causes a
reduced ability to see.
- Lexapro withdrawal - Rigors – Shivering or shaking
of the body as if chilled, preventing normal responses.
- Lexapro withdrawal - Skin Ulcer – An open sore or
infected skin eruption with swelling, redness, pus, and irritation.
- Lexapro withdrawal - Sleep Disorder – These are a
list of sleep disorders such as teeth grinding, insomnia, jet lag, sleep
walking, abnormally falling asleep during the middle of a conversation after
a full night’s rest, uncontrolled body motions keeping one awake, etc.
- Lexapro withdrawal - Suicide, Completed – An
attempted attack on oneself that is life threatening resulting in death.
- Lexapro withdrawal - Upper Respiratory Tract Infection
– Where the organs of breathing near the mouth such as the nose and sinuses,
become infected and are usually treated by antibiotics.
- Lexapro withdrawal - Urinary Hesitation – Hard to
start or hard to continue emptying one’s bladder.
- Lexapro withdrawal - Urinary Incontinence –
Urinating without intending to do so because of a weakening of the muscles
in the hip area from the drug affecting the nerves or the drug blocking a
persons thinking process.
- Lexapro withdrawal - Urinary Retention – The
inability to completely empty the bladder despite having the urge to do so.
This can lead to infections or damage to the urinary organs.
- Lexapro withdrawal - Urine Flow Decreased –
Dehydration of the body causing a lesser flow of urine than normal with the
body reabsorbing the waste.
- Lexapro withdrawal - Urine Output Decreased – A
condition where the output of urine produced in a 24-hour period is less
than 500 ml.
- Lexapro withdrawal - Weight Decreased –
Unintentional weight loss.
- Lexapro withdrawal – Weight Increased – An
unusual, usually rapid weight increase.
|
|
A Note From James Harper, Founder, The Road Back
1. The Road Back Basics
2. The Four Simple Steps
3. "Nutritionals" Used on The Road Back Program
4. Medication Side Effects
5. Things to Be Aware of
6. General Pre-Tapering and Tapering Instructions
7. Daily Journal
8. Graph Your Success
9. Pre-Taper for Benzodiazepines, Anti-Anxiety, Anticonvulsants and Sleep Medication
10. Pre-Taper For Antidepressants, Antipsychotics, and ADHD Medication
11. How to Taper Off Benzodiazepines, Anti-Anxiety, Anticonvulsants and Sleep Medications
12. How to Taper Off Antidepressants, Antipychotics and ADHD Medication
13. Once Off Medication
14. What to Do If You Have Already Started to Taper Off Your Medication or Quit Cold Turkey
15. How to Taper Off Multiple Medication
16. What Can be Done if You Have Never Taken Psychiatric Medication
17. The Science Behind The Road Back
Copyright Notice, Patent Pending
|
|